Skip to main content

View full-text article in PMC

. 2008 Dec 7;14(45):6970–6974. doi: 10.3748/wjg.14.6970

Table 1.

Pancreatic fistula rate based on clinical factors

Factors		Number of patients (%)	Leakage (%)	P value
Age (yr)	≥ 60	115 (66.9)	25 (21.7)	0.016
Age (yr)	< 60	57 (32.1)	5 (8.8)	0.016
Gender	Male	116 (67.4)	19 (16.4)	0.606
Gender	Female	56 (32.6)	11 (19.6)	0.606
Type of anastomosis	Duct-to-mucosa	133 (77.3)	22 (16.5)	0.582
Type of anastomosis	End-to-end	39 (22.7)	8 (19.6)	0.582
Pancreatic stent	Yes	58 (33.7)	11 (19.0)	0.712
Pancreatic stent	No	114 (66.3)	19 (16.7)	0.712
Texture of remnant pancreas	Hard	61 (58.5)	7 (16.3)	0.392
Texture of remnant pancreas	Soft	43 (41.5)	7 (23.0)	0.392
Pancreatic duct size	Dilated	60 (44.1)	4 (6.6)	0.001
Pancreatic duct size	Non-dilated	76 (55.9)	21 (27.6)	0.001
Pre-op bilirubin	≥ 1.3 mg/dL	92 (54.5)	15 (16.3)	0.674
Pre-op bilirubin	< 1.3 mg/dL	80 (46.5)	15 (18.8)	0.674
Pre-op albumin	≥ 3.1 g/dL	138 (80.2)	23 (16.7)	0.607
Pre-op albumin	< 3.1 g/dL	34 (19.8)	7 (20.6)	0.607
Pre-op WBC	≥ 10 000/mm³	29 (16.9)	7 (24.1)	0.349
Pre-op WBC	< 10 000/mm³	143 (83.1)	23 (16.1)	0.349